Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-009426
Filing Date
2023-06-08
Accepted
2023-06-08 16:21:33
Documents
1
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 form4-06082023_080630.html 4  
1 form4-06082023_080630.xml 4 6406
  Complete submission text file 0001415889-23-009426.txt   7804
Mailing Address C/O INTRABIOTICS PHARMACEUTICALS INC 1009 OAK HILL ROAD, SUITE 201 LAFAYETTE CA 94549
Business Address
Quart Barry D (Reporting) CIK: 0001384243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 231002198

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations